Tag: Aelis
Aelis Farma: promising results for AEF0117
(CercleFinance.com) – Aelis Farma announces today the publication of a series of studies around AEF0117, its first drug candidate dedicated to the treatment of disorders related to excessive cannabis consumption…
Aelis Farma: participates in World Down Syndrome Day
By Alexandra Saintpierre Published on 03/21/2023 at 6:11 p.m. Photo credit © Boursier.com / Kronos Agenda (Boursier.com)…
Aelis Farma: contribution of 200 kE to the liquidity contract
AS Published on 02/21/2023 at 7:40 p.m. Photo credit © SunocciPictures (Boursier.com) — The clinical-stage…
Aelis farma: Recruitment of a first phase 1/2 patient
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Aelis Farma: recruitment of a first phase 1/2 patient – 12/16/2022 at 12:38
(CercleFinance.com) – Aelis Farma announced on Friday the recruitment of a first patient as part of its phase 1/2 clinical study devoted to the treatment of cognitive disorders of trisomy…
Aelis Farma: positive results of safety studies with drug candidate AEF0217 – 11/15/2022 at 6:00 pm
Aelis Farma announces the positive results of safety studies in healthy volunteers and the authorization to initiate the first study in people with Down syndrome with its drug candidate AEF0217…
Aelis farma: Financing guaranteed until the end of 2024
Read also (CercleFinance.com) – The biopharmaceutical company Aelis Farma announced on Monday that it had ended the first half with cash of 39.8 million euros, which gives this brain disease…
Aelis Farma: financing guaranteed until the end of 2024 – 09/26/2022 at 14:14
(CercleFinance.com) – The biopharmaceutical company Aelis Farma announced on Monday that it had ended the first half with cash of 39.8 million euros, which gives this brain disease specialist financial…
Aelis Farma publishes its 2022 half-year financial results and confirms its development outlook – 09/26/2022 at 07:00
– 1st half of 2022 marked by the start of recruitment for the phase 2b study with AEF0117 in the treatment of cannabis addiction – Solid cash position at €39.8m…
Aelis Farma: the General Assembly will be held in Bordeaux
By Alexandra Saintpierre Published on 06/07/2022 at 8:24 p.m. Photo credit © Boursier.com …
Aelis Farma: start of recruitment for a study
Aelis Farma announces the recruitment of the first patient in the phase 2b study on AEF0117 in the treatment of the harmful effects of cannabis use, a study which should…
Aelis Farma: Oddo initiates ‘buy’ headline coverage
(CercleFinance.com) – Aelis Farma today announces the initiation of coverage of its stock by ODDO BHF, one of Europe’s leading independent financial services firms specializing in research, execution and advisory.…